Literature DB >> 11100734

Global histone acetylation and deacetylation in yeast.

M Vogelauer1, J Wu, N Suka, M Grunstein.   

Abstract

Histone acetyltransferases and deacetylases can be targeted to promoters to activate or repress genes. For example, the histone acetyltransferase GCN5 is part of a yeast multiprotein complex that is recruited by the DNA-binding activator protein GCN4 (refs 1-3). The histone deacetylase RPD3 complex is recruited to DNA by the repressor UME6 (refs 4, 5); similar mechanisms exist in other eukaryotes. However, deletion of RPD3 also increases expression of the PHO5 gene that is repressed by nucleosomes, and regulated by GCN5 (ref. 10) but not by UME6. We have determined whether acetylation and deacetylation are promoter specific at PHO5, by using antibodies against acetylated lysine residues and chromatin immunoprecipitation to examine the acetylation state of a 4.25-kilobase region surrounding the PHO5 gene. Here we show that this region is acetylated extensively by ESA1 and GCN5 and deacetylated by HDA1 and RPD3, and that widespread histone modification affects three separate chromosomal regions examined, which total 22kb. Our data indicate that targeted modification occurs in a background of global acetylation and deacetylation that not only reduces basal transcription, but also allows a rapid return to the initial state of acetylation when targeting is removed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100734     DOI: 10.1038/35044127

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  166 in total

1.  HDA2 and HDA3 are related proteins that interact with and are essential for the activity of the yeast histone deacetylase HDA1.

Authors:  J Wu; A A Carmen; R Kobayashi; N Suka; M Grunstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  Histone acetylation at promoters is differentially affected by specific activators and repressors.

Authors:  J Deckert; K Struhl
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Transcription-coupled repair in RNA polymerase I-transcribed genes of yeast.

Authors:  Antonio Conconi; Vyacheslav A Bespalov; Michael J Smerdon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

4.  Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP.

Authors:  N Vo; C Fjeld; R H Goodman
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 5.  Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

Authors:  Anton Eberharter; Peter B Becker
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

6.  Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors.

Authors:  Yael Katan-Khaykovich; Kevin Struhl
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

7.  Genome-wide location and regulated recruitment of the RSC nucleosome-remodeling complex.

Authors:  Huck Hui Ng; François Robert; Richard A Young; Kevin Struhl
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

8.  Hyperacetylation of chromatin at the ADH2 promoter allows Adr1 to bind in repressed conditions.

Authors:  Loredana Verdone; Jiansheng Wu; Kristen van Riper; Nataly Kacherovsky; Maria Vogelauer; Elton T Young; Michael Grunstein; Ernesto Di Mauro; Micaela Caserta
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

9.  Antagonistic remodelling by Swi-Snf and Tup1-Ssn6 of an extensive chromatin region forms the background for FLO1 gene regulation.

Authors:  A B Fleming; S Pennings
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

10.  Components of the SAGA histone acetyltransferase complex are required for repressed transcription of ARG1 in rich medium.

Authors:  Andrea R Ricci; Julie Genereaux; Christopher J Brandl
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.